Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?
We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.
Changes to how influencers can promote therapeutic goods in Australia
The Therapeutic Goods Administration has set out new guidelines that govern how influencers can promote products on social media in return for payment or free products or services from brands.
From idea to inception and beyond: Important learnings from female biotech founders
Female biotech founders took centre-stage at AusBiotech 2021 with the leaders of some of Australia’s most innovative start-ups coming together to discuss their experiences in the commercial scientific world.
Saving grace: Options if you disclose your invention without a patent application
Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.
Virus filtration patent gets clean bill of health
In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.
Extending the 12-month grace period for filing patent applications – what you need to know
Can the 12-month grace period for filing your patent application be extended? Yes, it can – but subject to the facts.
Why are embryonic stem cells not able to be patented in Australia?
Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?
Spotlight Series: Regenerative Medicine – Part 1
The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.
Draft roadmap for Australian regenerative medicine released for comment
AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.
Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom
Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.
Ono: Broader is not always better
Why is patent term extension is so important to companies developing and commercialising new pharmaceutical substances?
CRISPR-Cas9 Update: Collision of Trends in IP and Life Sciences
CRISPR-Cas9 genome editing may not just be the greatest scientific breakthrough of this century, but also provides many lessons on patenting life science technologies.